Contact
searchSearch
HMP Global

November 2014 - FRMC

Investigation of Canagliflozin Use in a Real-World Setting
11/14/2014
In a new study, researchers investigated the demographic and clinical factors of patients initiating canagliflozin or DPP-4 therapy in a large commercially insured US population.
In a new study, researchers investigated the demographic and clinical factors of patients initiating canagliflozin or DPP-4 therapy in a large commercially insured US population.
In a new study, researchers...
11/14/2014
First Report Managed Care
Study Examines Cost-Effectiveness of Interferon for MS
11/14/2014
Clinical data from the EVIDENCE study found that the cost-effectiveness of subcutaneous interferon (IFN) ß-1a 44 mcg given 3 times weekly was favorable compared with intramuscular IFN ß-1a 30 mcg given once weekly for relapsing forms of...
Clinical data from the EVIDENCE study found that the cost-effectiveness of subcutaneous interferon (IFN) ß-1a 44 mcg given 3 times weekly was favorable compared with intramuscular IFN ß-1a 30 mcg given once weekly for relapsing forms of...
Clinical data from the EVIDENCE...
11/14/2014
First Report Managed Care
Examining Breakthrough Designation Labeling
11/14/2014
Breakthrough therapy designation was established as part of the FDA Safety and Innovation Act of 2012.
Breakthrough therapy designation was established as part of the FDA Safety and Innovation Act of 2012.
Breakthrough therapy designation...
11/14/2014
First Report Managed Care
Budget Model Analyzes Formulary Costs for Obesity Drugs
11/14/2014
A recent study evaluated formulary cost implications associated with the addition of naltrexone/bupropion for the treatment of obesity in the United States.
A recent study evaluated formulary cost implications associated with the addition of naltrexone/bupropion for the treatment of obesity in the United States.
A recent study evaluated...
11/14/2014
First Report Managed Care
Tbo-Filgrastim Shows Significant Cost Saving for Payers
11/14/2014
A pharmacy budget impact model to estimate, from a payer perspective, the impact of the introduction of tbo-filgrastim as an alternative short-acting granulocyte colony-stimulating factor on a pharmacy budget showed a total annual plan cost...
A pharmacy budget impact model to estimate, from a payer perspective, the impact of the introduction of tbo-filgrastim as an alternative short-acting granulocyte colony-stimulating factor on a pharmacy budget showed a total annual plan cost...
A pharmacy budget impact model...
11/14/2014
First Report Managed Care
More Generics, Biosimilars, and Orphan Drugs on the Horizon
11/14/2014
As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...
As patented products expire, >$13 billion in brand-name specialty medications are expected to face generic competition in the next 5 years, and it is projected that there is a $31.8 billion opportunity in the market for biosimilars through...
As patented products expire,...
11/14/2014
First Report Managed Care
Tools to Help Payers Manage Growing Drug Costs
11/14/2014
As with other specialty drugs, the high cost of medications to treat hepatitis C presents payers with the challenge of helping their members get the medications they need, while attempting to maintain healthcare costs.
As with other specialty drugs, the high cost of medications to treat hepatitis C presents payers with the challenge of helping their members get the medications they need, while attempting to maintain healthcare costs.
As with other specialty drugs,...
11/14/2014
First Report Managed Care

News

News
Study Examines Costs for Various Psoriasis Treatments
11/14/2014
The economic burden of psoriasis in the United States is significant, as it is estimated to cost $11.25 billion annually in total direct and indirect healthcare costs, according to statistics from the National Psoriasis Foundation.
The economic burden of psoriasis in the United States is significant, as it is estimated to cost $11.25 billion annually in total direct and indirect healthcare costs, according to statistics from the National Psoriasis Foundation.
The economic burden of psoriasis...
11/14/2014
First Report Managed Care

Department

Conference Insider
AMCP Addresses Stance on Federal and State Legislative and Regulatory Moves
11/14/2014
Legislation on medication therapy management expansion and Medicare drug price negotiations are being discussed on the federal level, while states are considering legislation in the areas of biosimilars, controlled substances, and benefit...
Legislation on medication therapy management expansion and Medicare drug price negotiations are being discussed on the federal level, while states are considering legislation in the areas of biosimilars, controlled substances, and benefit...
Legislation on medication...
11/14/2014
First Report Managed Care
Conference Insider
Paradigm Change: New Guidelines on Managing Cholesterol
11/14/2014
“This is a large paradigm change for clinicians,” said Joseph Saseen, PharmD, professor, vice chair, department of clinical pharmacy, professor, department of family medicine, University of Colorado Skaggs School of Pharmacy and...
“This is a large paradigm change for clinicians,” said Joseph Saseen, PharmD, professor, vice chair, department of clinical pharmacy, professor, department of family medicine, University of Colorado Skaggs School of Pharmacy and...
“This is a large paradigm change...
11/14/2014
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Call for Gastric Surgery to be Standard Diabetes Treatment
05/25/2016
People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication.
People with diabetes should be offered gastric surgery as a standard treatment option which could help control it for years without medication.
People with diabetes should be...
05/25/2016
First Report Managed Care
News
Montana Lawmakers Propose New Abortion Regulations for Medicaid Reimbursement
01/24/2023
Under the proposed change, providers would be required to have state approval before performing an abortion and submit supporting documents to demonstrate the procedure's medical necessity.
Under the proposed change, providers would be required to have state approval before performing an abortion and submit supporting documents to demonstrate the procedure's medical necessity.
Under the proposed change,...
01/24/2023
First Report Managed Care
Trends in Coronary Revascularization Procedures
08/22/2011
One of the most common major medical procedures provided by the healthcare system in the United States, coronary revascularization, is performed >1 million times each year. The procedure comprises coronary artery bypass graft (CABG)...
One of the most common major medical procedures provided by the healthcare system in the United States, coronary revascularization, is performed >1 million times each year. The procedure comprises coronary artery bypass graft (CABG)...
One of the most common major...
08/22/2011
First Report Managed Care
News
Insurer wants focus on what drives up health costs
03/28/2011
03/28/2011
First Report Managed Care
News
Takeda’s Successor Drug to Actos Fails to Win Approval
04/26/2012
04/26/2012
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

November 2014 Volume 11 Issue 11

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use